Emphasizing that innovation and internationalization are shared goals for both CAP and Hengrui Pharma, Zhao said this collaboration reflects a mutual commitment to scientific progress and national responsibility.

"By working together, the two sides can strive to overcome the greatest challenges in pancreatic disease prevention and treatment, a goal akin to that of mountaineers successfully scaling Mount Qomolangma," he said.

It has been learned that CAP and Hengrui Pharma will jointly promote international cooperation, support Asia-Pacific and global pancreatic disease summits, and organize branded academic conferences to enhance hospital management and oncology care capabilities.